He Zhengxiu, Sun Jian, Wang Mengmeng, Chen Shanshan, Mao Guoxin, Yang Li
Department of Oncology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.
Department of Gastroenterology, Dongtai People's Hospital, Yancheng, China.
Transl Cancer Res. 2025 Feb 28;14(2):796-807. doi: 10.21037/tcr-24-1283. Epub 2025 Feb 26.
Talin1 serves as a crucial element within the multiprotein adhesion complexes that facilitate processes such as cell migration, adhesion, and integrin signaling. This study aimed to explore the underlying role of Talin1 Ser425 phosphorylation in the development of colorectal cancer (CRC).
Blank plasmids, non-phosphorylatable mutant Talin1 S425A plasmids, and phosphorylation-mimetic mutant Talin1 S425D plasmids were constructed and used for transfection of CRC cells. The expression of mRNA and protein in CRC cells or tumor tissues was assessed by The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), and UALCAN databases, immunohistochemistry (IHC), and Western blot (WB). Cell proliferation was assessed via 5-ethynyl-2-deoxyuridine (EDU) proliferation assay and colony formation assay. Cell migration and invasion were detected by wound healing assay and transwell assay. Cell apoptosis was assessed by flow cytometry. The Kaplan-Meier Plotter was used to evaluate the prognostic value of mRNA in CRC.
TLN1 was markedly downregulated in CRC tissues while the level of Talin1 Ser425 phosphorylation in CRC tissues and aggressive CRC cells was relatively higher. The S425A mutant inhibited CRC cell proliferation, migration, and invasion, whereas the S425D mutant promoted these processes. Flow cytometry assay showed that cell apoptosis was induced by S425A mutant and suppressed by S425D mutant in RKO cells. Further investigation suggested that CDK5 might be responsible for Talin1 phosphorylation.
Talin1 Ser425 phosphorylation is of great importance in CRC development and Talin1 is supposed to be a potential tumor marker and therapeutic target for CRC.
踝蛋白1是多蛋白黏附复合物中的关键成分,有助于细胞迁移、黏附及整合素信号传导等过程。本研究旨在探讨踝蛋白1丝氨酸425磷酸化在结直肠癌(CRC)发生发展中的潜在作用。
构建空白质粒、非磷酸化突变型踝蛋白1 S425A质粒和模拟磷酸化突变型踝蛋白1 S425D质粒,并用于转染CRC细胞。通过癌症基因组图谱(TCGA)、基因型-组织表达(GTEx)和UALCAN数据库、免疫组织化学(IHC)及蛋白质免疫印迹法(WB)评估CRC细胞或肿瘤组织中mRNA和蛋白质的表达。通过5-乙炔基-2'-脱氧尿苷(EDU)增殖试验和集落形成试验评估细胞增殖。通过伤口愈合试验和Transwell试验检测细胞迁移和侵袭。通过流式细胞术评估细胞凋亡。使用Kaplan-Meier Plotter评估mRNA在CRC中的预后价值。
CRC组织中TLN1明显下调,而CRC组织和侵袭性CRC细胞中踝蛋白1丝氨酸425的磷酸化水平相对较高。S425A突变体抑制CRC细胞增殖、迁移和侵袭,而S425D突变体促进这些过程。流式细胞术检测显示,RKO细胞中S425A突变体诱导细胞凋亡,S425D突变体抑制细胞凋亡。进一步研究表明,CDK5可能是踝蛋白1磷酸化的原因。
踝蛋白1丝氨酸425磷酸化在CRC发生发展中至关重要,踝蛋白1有望成为CRC潜在的肿瘤标志物和治疗靶点。